title: [Effect of perindopril on hemostasis and functional status of pancreas in patients with ischemic heart disease].
abstract: Systemic circulation compromise in patients with cardiac insufficiency results in disturbances of functional state of pancreas. The Willebrand's Factor takes a definite role in this pathological process. The usage of Peridopril 4 mg daily during the treatment decreases significantly Willebrand's Factor activity and normalizes function of the pancreas.
authors.forename: V I
authors.initials: VI
authors.lastname: Koshlia
authors.forename: L M
authors.initials: LM
authors.lastname: Zelens'ka
authors.forename: I V
authors.initials: IV
authors.lastname: Zaïka
authors.forename: A V
authors.initials: AV
authors.lastname: Zaïka
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis; D004334:Drug Administration Schedule; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D010179:Pancreas / Q000187:drug effects / Q000503:physiopathology*; D020913:Perindopril / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014841:von Willebrand Factor / Q000032:analysis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D014841:von Willebrand Factor; D020913:Perindopril